FDA to hold a joint committee meeting

The Anesthetic & Analgesic Drug Products Advisory Committee and the Drug Safety & Risk Management Advisory Committee provide input and advice on strategies to increase the availability of naloxone products intended for use in the community. Participants include President & CEO Kramer of Emergent Biosolutions and Medical Affairs Director Mariano of Insys Therapeutics in the meeting being held at the FDA Silver Spring, MD offices on December 17 at 8 am.

Webcast: https://collaboration.fda.gov/aadpacdsarm2018
https://thefly.com/landingPageNews.php?id=2837873